Recent share performance snapshot

Herbalife (HLF) has drawn fresh attention after a recent share price move, with the stock closing at $16.28. Over the past month, the shares show a 13.1% gain, in contrast with a 5.6% decline over the past 3 months.

That recent 13.1% 1 month share price return comes after a softer 3 month period and sits alongside a 1 year total shareholder return of 122.4%. This suggests momentum has picked up again, while longer term holders have already seen substantial gains.

If Herbalife’s move has you thinking about where growth could appear next in the market, it may be worth scanning 18 top founder-led companies

With Herbalife trading at $16.28 against a $17.50 analyst target and an indicated intrinsic discount of about 45%, you have to ask: is this a mispriced story, or is the market already baking in expectations for future growth?

Most Popular Narrative: 1.3% Undervalued

The most followed narrative places Herbalife’s fair value at $16.50, just above the recent $16.28 close, and builds a case around earnings, margins and growth expectations.

The analysts have a consensus price target of $16.5 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.

Want to see what sits behind that tight gap between fair value and the current price? The narrative leans heavily on future earnings growth, profit margins and valuation multiples that are very different from the wider sector. You may be curious which assumptions really carry the weight in that $16.50 figure and how far the implied multiple stretches the current P/E story.

Result: Fair Value of $16.50 (UNDERVALUED)

However, you also need to weigh the risk that tighter global regulation of multi level marketing and weaker demand for processed supplements could limit the potential upside in this story.

Next Steps

With sentiment clearly mixed, both risks and rewards are on the table. It makes sense to review the details and form your own view using 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If Herbalife has caught your eye, do not stop there. A few minutes with a focused stock screener can surface opportunities you might otherwise miss.

• Target potential value by reviewing companies flagged in the 51 high quality undervalued stocks.
• Prioritise resilience by scanning the 67 resilient stocks with low risk scores for businesses with steadier risk profiles.
• Spot earlier stage opportunities with quality traits using the screener containing 25 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.